[1] Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1998;41(8):1343-55.
[2] Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis and cartilage. 2013;21(9):1145-53.
[3] Michael JW, Schlüter-Brust KU, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Deutsches Arzteblatt International. 2010;107(9):152-62. https://doi.org/10.3238/arztebl.2010.0152.
[4] American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee: evidence-based guideline. J Am Acad Orthop Surg. 2013;21(9):577-9.
[5] Watson M. Management of patients with osteoarthritis. Pharmaceutical Journal. 1997;259(6957):296-7.
[6] Marhofer P, Greher M, Kapral S. Ultrasound guidance in regional anaesthesia. British journal of anaesthesia. 2005;94(1):7-17.
[7] Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of rheumatology. 1988;15(12):1833-40.
[8] Blankenbaker DG, De Smet AA, Stanczak JD, Fine JP. Lumbar radiculopathy: treatment with selective lumbar nerve blocks—comparison of effectiveness of triamcinolone and betamethasone injectable suspensions. Radiology. 2005;237(2):738-41. https://doi.org/10.1148/radiol.2372041406.
[9] Devor M, Govrin-Lippmann R, Raber P. Corticosteroids suppress ectopic neural discharge originating in experimental neuromas. Pain. 1985;22(2):127-37. https://doi.org/10.1016/0304-3959(85)90173-3.
[10] Johansson A, Hao J, Sjölund B. Local corticosteroid application blocks transmission in normal nociceptive Cāfibres. Acta Anaesthesiologica Scandinavica. 1990;34(5):335-8. https://doi.org/10.1111/j.1399-6576.1990.tb03097.x.